tiprankstipranks
Trending News
More News >
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
US Market
Advertisement

Ocular Therapeutix (OCUL) Technical Analysis

Compare
1,437 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
3Neutral
4Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Ocular Therapeutix’s (OCUL) Moving Averages Convergence Divergence (MACD) indicator is 0.57, suggesting Ocular Therapeutix is a Buy.
Ocular Therapeutix’s (OCUL) 20-Day exponential moving average is 12.01, while Ocular Therapeutix’s (OCUL) share price is $12.62, making it a Buy.
Ocular Therapeutix’s (OCUL) 50-Day exponential moving average is 10.84, while Ocular Therapeutix’s (OCUL) share price is $12.62, making it a Buy.

Ocular Therapeutix (OCUL) Pivot Points

Aug 18, 2025, 11:07 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
11.68
11.91
12.28
12.51
12.88
13.11
13.48
Fibonacci
11.91
12.14
12.28
12.51
12.74
12.88
13.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ocular Therapeutix (OCUL) Moving Averages

Aug 18, 2025, 11:07 AM
Period
Simple
Exponential
MA5
12.56Buy
12.54Buy
MA10
12.42Buy
12.38Buy
MA20
12.12Buy
12.01Buy
MA50
10.58Buy
10.84Buy
MA100
9.02Buy
9.81Buy
MA200
8.78Buy
9.38Buy
Ocular Therapeutix’s (OCUL) 10-Day exponential moving average is 12.38, while Ocular Therapeutix’s (OCUL) share price is $12.62, making it a Buy.
Ocular Therapeutix’s (OCUL) 100-Day exponential moving average is 9.81, while Ocular Therapeutix’s (OCUL) share price is $12.62, making it a Buy.
Ocular Therapeutix’s (OCUL) stock price is $12.62 and Ocular Therapeutix’s (OCUL) 50-day simple moving average is 10.58, creating a Buy signal.
Ocular Therapeutix’s (OCUL) stock price is $12.62 and Ocular Therapeutix’s (OCUL) 100-day simple moving average is 9.02, creating a Buy signal.
Ocular Therapeutix’s (OCUL) stock price is $12.62 and Ocular Therapeutix’s (OCUL) 200-day simple moving average is 8.78, creating a Buy signal.

Ocular Therapeutix (OCUL) Technical Indicators

Aug 18, 2025, 11:07 AM
Name
Value
Implied Action
RSI (14)
67.54
Neutral
STOCH (9,6)
86.27
Sell
STOCHRSI (14)
86.27
Sell
MACD (12,26)
0.57
Buy
ADX (14)
40.82
Neutral
Williams %R
-12.45
Sell
CCI (14)
115.29
Sell
ATR (14)
0.58
-
Ultimate Oscillator
64.82
Neutral
ROC
4.47
Buy
Ocular Therapeutix’s (OCUL) Relative Strength Index (RSI) is 67.54, creating a Neutral signal.
Ocular Therapeutix’s (OCUL) Trend Strength Indicator (ADX) is 40.82, creating a Neutral signal.
Ocular Therapeutix’s (OCUL) Commodity Channel Index (CCI) is 115.29, creating a Sell signal.
Ocular Therapeutix’s (OCUL) Price Rate of Change (ROC) is 4.47, creating a Buy signal.

FAQ

Is OCUL a Buy, Hold, or Sell?
Based on OCUL’s technical indicators, OCUL is a Buy.
    What is OCUL’s RSI (14)?
    OCUL’s RSI (14) is 67.54, which suggests OCUL is a Neutral.
      What is OCUL’s MACD?
      OCUL’s MACD is 0.57, which suggests OCUL is a Buy.
        What is OCUL’s 5-day moving average?
        OCUL’s 5-day moving average is 12.56, which suggests OCUL is a Buy.
          What is OCUL’s 20-day moving average?
          OCUL 20-day moving average is 12.12, which suggests OCUL is a Buy.
            What is OCUL’s 50-day moving average?
            OCUL’s 50-day moving average is 10.58, which suggests OCUL is a Buy.
              What is OCUL’s 200-day moving average?
              OCUL’s 200-day moving average is 8.78, which suggests OCUL is a Buy.
                What is OCUL’s Williams % R (14)?
                OCUL’s Williams % R (14) is -12.45, which suggests OCUL is a Sell.
                  What is OCUL’s CCI (14)?
                  OCUL’s CCI (14) is 115.29, which suggests OCUL is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis